logo

This website uses cookies to ensure you get the best experience on our website.

Read through the Privacy Policy to understand better

 Go Back

FDA approves Pfizer-BioNTech vaccine for children aged between 5 & 11

By Yashasvini Razdan - Oct 29, 2021, 11:44 PM ET
Last Updated - Feb 13, 2024, 08:53 AM EST
Pfizer_Building
expected FDA clearance came after the agency’s Vaccines and Related Biological Products Advisory Committee voted on Tuesday in favor of a smaller dose of the Pfizer vaccine for young children

“As a mother and a physician, I know that parents, caregivers, school staff, and children have been waiting for today’s authorization. Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy,” acting FDA Commissioner Dr. Janet Woodcock said in a statement

With this approval, the shots will be available to nearly 28 million kids

The vaccine shot’s dosage is one-third of that given to adults

Sponsored

The FDA authorized the use of Pfizer Inc(PFE)and BioNTech’s COVID-19 vaccine for children aged between 5 and 11, on Friday, making the vaccine shots available to nearly 28 million children.

“As a mother and a physician, I know that parents, caregivers, school staff, and children have been waiting for today’s authorization. Vaccinating younger children against COVID-19 will bring us closer to returning to a sense of normalcy,” acting FDA Commissioner Dr. Janet Woodcock said in a statement.

By continuing to use this site, you agree to our terms and conditions
Sponsored
Sponsored
Sponsored
Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
    Phone: +1 (425) 414-0184
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
    Phone: +91 80 4902 2100
4.2 20250324